Remember that if all else fails, they have a super drug funded by the US army!
This is from the Australian today:
"Avexa (AVX) is in a phase III trial for its HIV drug Apricitabine and Neuren (NEU) has a phase III trial under way in the US for its brain-protective drug Glypromate.
Both have been savaged by investors and are woefully undervalued. So much so that they represent either 20-baggers or are in danger of going out the back door."
http://www.theaustralian.news.com.au/story/0,25197,24441506-5001942,00.html
20 bagger
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.15 |
Change
-0.940(5.50%) |
Mkt cap ! $2.064B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $16.33 | $14.65 | $25.91M | 1.638M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 125 | $16.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |